Tie J, Wu H, Liu W, Li Y, Li L, Zhao S
Neural Plast. 2025; 2025:3934591.
PMID: 39949834
PMC: 11824863.
DOI: 10.1155/np/3934591.
Xu W, Yan J, Shao A, Lenahan C, Gao L, Wu H
Fundam Res. 2024; 4(6):1389-1397.
PMID: 39734532
PMC: 11670711.
DOI: 10.1016/j.fmre.2023.04.016.
Dastan M, Rajaei Z, Sharifi M, Salehi H
Metab Brain Dis. 2024; 40(1):12.
PMID: 39556267
DOI: 10.1007/s11011-024-01441-5.
Babygirija R, Sonsalla M, Mill J, James I, Han J, Green C
Nat Commun. 2024; 15(1):5217.
PMID: 38890307
PMC: 11189507.
DOI: 10.1038/s41467-024-49589-z.
Kuntic M, Hahad O, Munzel T, Daiber A
Antioxidants (Basel). 2024; 13(3).
PMID: 38539800
PMC: 10967531.
DOI: 10.3390/antiox13030266.
Insights into Gastrointestinal Redox Dysregulation in a Rat Model of Alzheimer's Disease and the Assessment of the Protective Potential of D-Galactose.
Homolak J, Varvaras K, Sciacca V, Babic Perhoc A, Virag D, Knezovic A
ACS Omega. 2024; 9(10):11288-11304.
PMID: 38496956
PMC: 10938400.
DOI: 10.1021/acsomega.3c07152.
The effect of intra-nasal co-treatment with insulin and growth factor-rich serum on behavioral defects, hippocampal oxidative-nitrosative stress, and histological changes induced by icv-STZ in a rat model.
Ghaffari M, Rafati A, Karbalaei N, Haghani M, Nemati M, Sefati N
Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(7):4833-4849.
PMID: 38157024
DOI: 10.1007/s00210-023-02899-3.
A Review on Bioactive Anthraquinone and Derivatives as the Regulators for ROS.
Zhao L, Zheng L
Molecules. 2023; 28(24).
PMID: 38138627
PMC: 10745977.
DOI: 10.3390/molecules28248139.
Simple model systems reveal conserved mechanisms of Alzheimer's disease and related tauopathies.
Jiang Y, MacNeil L
Mol Neurodegener. 2023; 18(1):82.
PMID: 37950311
PMC: 10638731.
DOI: 10.1186/s13024-023-00664-x.
Evaluation of the Neuroprotective Effect of Organic Selenium Compounds: An in Vitro Model of Alzheimer's Disease.
Pereira M, Lima L, Souza J, Costa N, Silva J, Guiloski I
Biol Trace Elem Res. 2023; 202(7):2954-2965.
PMID: 37803188
DOI: 10.1007/s12011-023-03893-9.
Protein restriction slows the development and progression of Alzheimer's disease in mice.
Babygirija R, Sonsalla M, Mill J, James I, Han J, Green C
Res Sq. 2023; .
PMID: 37790423
PMC: 10543316.
DOI: 10.21203/rs.3.rs-3342413/v2.
Current Advances in Mitochondrial Targeted Interventions in Alzheimer's Disease.
Sousa T, Moreira P, Cardoso S
Biomedicines. 2023; 11(9).
PMID: 37760774
PMC: 10525414.
DOI: 10.3390/biomedicines11092331.
Reactive Sulfur Species Omics Analysis in the Brain Tissue of the 5xFAD Mouse Model of Alzheimer's Disease.
Kinno A, Kasamatsu S, Akaike T, Ihara H
Antioxidants (Basel). 2023; 12(5).
PMID: 37237971
PMC: 10215359.
DOI: 10.3390/antiox12051105.
Insights from on Aβ- and tau-induced mitochondrial dysfunction: mechanisms and tools.
Varte V, Munkelwitz J, Rincon-Limas D
Front Neurosci. 2023; 17:1184080.
PMID: 37139514
PMC: 10150963.
DOI: 10.3389/fnins.2023.1184080.
Dendrimers and Derivatives as Multifunctional Nanotherapeutics for Alzheimer's Disease.
Moreira D, Santos S, Leiro V, Pego A
Pharmaceutics. 2023; 15(4).
PMID: 37111540
PMC: 10140951.
DOI: 10.3390/pharmaceutics15041054.
Antioxidant Compounds from Edible Mushrooms as Potential Candidates for Treating Age-Related Neurodegenerative Diseases.
Liuzzi G, Petraglia T, Latronico T, Crescenzi A, Rossano R
Nutrients. 2023; 15(8).
PMID: 37111131
PMC: 10145943.
DOI: 10.3390/nu15081913.
Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetes.
McNeilly A, Gallagher J, Evans M, de Galan B, Pedersen-Bjergaard U, Thorens B
Diabetologia. 2023; 66(7):1340-1352.
PMID: 37015997
PMC: 10244284.
DOI: 10.1007/s00125-023-05907-6.
Betanin mitigates scopolamine-induced cognitive impairment by restoring cholinergic function, boosting brain antioxidative status, and increasing BDNF level in the zebrafish model.
Thawkar B, Kaur G
Fish Physiol Biochem. 2023; 49(2):335-349.
PMID: 36991213
DOI: 10.1007/s10695-023-01185-6.
Dietary Protection against Cognitive Impairment, Neuroinflammation and Oxidative Stress in Alzheimer's Disease Animal Models of Lipopolysaccharide-Induced Inflammation.
Decandia D, Gelfo F, Landolfo E, Balsamo F, Petrosini L, Cutuli D
Int J Mol Sci. 2023; 24(6).
PMID: 36982996
PMC: 10051444.
DOI: 10.3390/ijms24065921.
Antioxidant Compounds in the Treatment of Alzheimer's Disease: Natural, Hybrid, and Synthetic Products.
Hatami M, Mortazavi M, Baseri Z, Khani B, Rahimi M, Babaei S
Evid Based Complement Alternat Med. 2023; 2023:8056462.
PMID: 36865743
PMC: 9974281.
DOI: 10.1155/2023/8056462.